文献速递头颈部肿瘤放疗胸部肿瘤放疗

老年评估预测头颈癌与肺癌放疗耐受性、生活质量及结局

Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2016-12-02

前瞻性队列研究纳入50例≥65岁头颈癌或肺癌接受根治性放疗或放化疗患者,46例可评估,基线37%存在功能障碍。功能障碍与治疗耐受性无关,但基线功能障碍者从放疗结束到6周随访时躯体、角色功能和社会领域持续下降(均P<.01),且某些患者报告结局严重度更高。

要点

  • 基线功能障碍与放疗或放化疗耐受性无显著关联。
  • 基线功能障碍者放疗结束后至6周随访生活质量持续下降。
  • 基线功能障碍与某些患者报告结局严重度更高相关。

核心结论

  • 治疗前功能障碍与头颈癌或肺癌放疗患者生活质量持续下降及未恢复相关。
  • 功能障碍与放疗或放化疗耐受性无显著关联。

研究设计与样本

  • 前瞻性队列研究,纳入50例≥65岁头颈癌或肺癌接受根治性放疗或放化疗患者,46例可评估。
  • 平均年龄72.5岁(范围65-92岁),基线37%存在功能障碍(IADL评分<14)。

主要发现

  • 放疗或放化疗耐受性差发生于39%的患者。
  • 功能障碍与治疗耐受性无关联。
  • 基线功能障碍者从基线至放疗结束角色功能(P=.01)和全球健康评分(P=.04)下降较少。
  • 从放疗结束至6周随访,基线功能障碍者躯体、角色功能和社会领域更可能持续下降(均P<.01)。
  • 基线功能障碍与某些患者报告结局严重度更高相关。

关键数值与推荐

  • 功能障碍定义为工具性日常生活活动量表评分<14。
  • 耐受性差定义为住院、治疗延迟>3天、放疗或放化疗方案改变或死亡。

临床怎么用

  • 对老年头颈癌或肺癌放疗患者,治疗前应进行老年评估以识别功能障碍。
  • 基线功能障碍患者需关注放疗后生活质量持续下降风险并加强支持。

局限性

  • 样本量较小(50例入组,46例可评估),需更大规模研究进一步阐明老年评估的预测价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the association between functional status based on a geriatric assessment (GA) and outcomes of tolerance to treatment in patients with lung or head and neck cancer receiving radiation therapy (RT) or chemoradiation (CRT). METHODS AND MATERIALS: A prospective cohort study was conducted in patients aged ≥65 years with head and neck cancer or lung cancer undergoing curative intent RT or CRT. Pretreatment GA, health-related quality of life (HRQoL), and patient-reported outcomes (PRO) were obtained. Questionnaires were repeated biweekly during RT and at 6 weeks after treatment. Dysfunction was defined as scores <14 on the Instrumental Activities of Daily Living scale. Poor tolerance to treatment was defined by hospitalization, >3-day treatment delay, change in RT or CRT regimen, or death. Associations of dysfunction with tolerance to radiation therapy, HRQoL changes, and PRO ratings were evaluated. RESULTS: Of the 50 patients accrued, 46 had evaluable data. Mean age was 72.5 years (range, 65-92 years). At baseline, 37% had dysfunction. Poor tolerance to RT or CRT occurred in 39%. There was no association between dysfunction and tolerance. Patients with dysfunction had lower baseline HRQoL scores. From baseline to end of RT, those with baseline dysfunction had less of a decline in Role Functioning (P=.01) and Global Health Score (P=.04) domains. However, from end of RT to 6-week follow-up, those with dysfunction were more likely to continue to drop in the Physical, Role Functioning, and Social domains (all P<.01). Dysfunction at baseline was also associated with higher severity of certain PROs. CONCLUSIONS: Pretreatment dysfunction was associated with continued decline and lack of recovery of HRQoL in this patient population. Larger studies could further elucidate the GA's predictive value.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. VanderWalde NA, Deal AM, Comitz E, et al. Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016. PMID: 28258889. doi:10.1016/j.ijrobp.2016.11.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。